From the world-class research of Dr Maïwenn Kersaudy-Kerhoas comes Natantis' expertise in solving significant problems using microfluidics.
Meeting the customer need of reducing preparation time while increasing quality and quantity of the cfNA isolated, CNAsafe brings a revolution to sample preparation.
We aim to be a world leader in sample preparation for liquid biopsy.
Natantis’ lead product CNAsafe is the world’s first automated benchtop system that standardises the way in which samples are prepared for use in a variety of liquid biopsies. We anticipate first commercial sale of the platform in 2021.